FSSAI Cracks Down On Six Nutraceutical Companies Over Serious Safety Violations

FSSAI has initiated action against six nutraceutical companies after inspections revealed excessive nutrients, prohibited ingredients, expired materials and serious manufacturing violations.

News Desk
Edited By: News Desk
Rimpi Jindal
Reported By: Rimpi Jindal
Share This:

FSSAI has initiated action against six nutraceutical companies after inspections revealed excessive nutrients, prohibited ingredients, etc. (Social Media)

New Delhi: The Food Safety and Standards Authority of India (FSSAI) has initiated strict regulatory action against six nutraceutical companies after inspections exposed serious violations involving product quality, manufacturing practices and misleading health claims.

The inspections revealed multiple irregularities, including excessive levels of vitamins and minerals, use of prohibited ingredients, expired raw materials and inadequate hygiene standards. Some companies have also faced action involving the suspension of their food safety licences.

The companies under scrutiny are Airon Herbals, Aquabliss Lifesciences, Ruscam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare and Vedant Remedies. Investigations found different types of violations at their manufacturing facilities and in their products.

Airon Herbals: Excessive Nutrient Levels and Misleading Claims

Two products manufactured by Airon Herbals were found to have irregularities. Its Lycove Syrup contained higher-than-permitted quantities of thiamine, vitamin E, copper, selenium and zinc.

The company's Maxford Knee Relief product also came under scrutiny for allegedly using misleading claims and images suggesting relief from knee pain. The product was found to contain excess thiamine, while details of certain herbal ingredients were not disclosed as required under regulations.

Aquabliss: Expired Raw Materials Found at Factory

An inspection of Aquabliss Lifesciences' manufacturing facility revealed the use of expired raw materials. Investigators also found that cleanliness and hygiene conditions at the premises were unsatisfactory, raising concerns over the company's manufacturing practices and compliance with food safety requirements.

Ruscam Healthcare: Use of an Unapproved Ingredient

Ruscam Healthcare Private Limited was found using shilajit in a product where the ingredient was not permitted. The inspection also highlighted shortcomings in maintaining essential records and documentation required under food safety regulations.

Supercure Biotech: Questions Over Capsule Composition

Several violations were detected during the inspection of Supercure Biotech. Its Gemcolin 9G capsules contained 100 micrograms of biotin, against the maximum permitted limit of 40 micrograms.

The company also faced scrutiny over a product marketed as vitamin E capsules, which reportedly contained wheat oil, making its product name misleading. Information about certain additives used in food products was also not provided.

In another major finding, Superbiotic capsules manufactured by the company contained microorganisms whose use is not permitted and which could pose health risks.

Ambico Ayurvedic: Expired Ingredients Used in Production

Inspectors found that Ambico Ayurvedic Healthcare was using expired raw materials and ingredients to manufacture nutraceutical products. Poor hygiene and inadequate cleanliness at its manufacturing facility were also reported, raising concerns about product quality and consumer safety.

Vedant Remedies: Lapses in Flavour Manufacturing

Vedant Remedies Private Limited was found using expired materials to manufacture artificial cardamom and strawberry flavours. The inspection also identified shortcomings in factory maintenance, sanitation, basic production infrastructure and testing arrangements.

FSSAI Signals Tougher Action Against Violators

Taking the findings seriously, FSSAI has indicated that companies compromising food safety standards will face strict regulatory measures. Violations involving poor hygiene, expired ingredients, excessive nutrient levels and misleading product claims are being treated as serious compliance issues.

The action serves as a warning to manufacturers selling products in the name of health and nutrition while allegedly compromising consumer safety. It also highlights the importance of stricter monitoring and accountability in the nutraceutical industry, where product quality remains a key concern for consumers.

Latest News

×